Berraondo, Pedro
Sanmamed, Miguel F.
Ochoa, María C
Etxeberria, Iñaki
Aznar, Maria A.
Pérez-Gracia, José Luis
Rodríguez-Ruiz, María E.
Ponz-Sarvise, Mariano
Castañón, Eduardo
Melero, Ignacio
Article History
Received: 19 June 2018
Revised: 4 October 2018
Accepted: 8 October 2018
First Online: 9 November 2018
Competing interests
: I.M. is a consultant for Bristol Myers Squibb, Roche-Genentech, MedImmune, Merck Serono, Bioncotech, F-STAR, Genemab and Tusk. He receives grants from Bristol Myers Squibb, Roche-Genentech, and Alligator. J.L.P.-G. is an advisor to Bristol Myers, Roche-Genentech and Servier. The other authors declare no competing interests.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).